Indovazin
Producer: Actavis Ltd. (Aktavis Ltd.) Switzerland
Code of automatic telephone exchange: M02AA23
Release form: Soft dosage forms. Gel.
General characteristics. Structure:
Active agent: indometacin of 3%, троксерутин 2%.
Pharmacological properties:
Analgeziruyushchy; antiinflammatory local.
Pharmacodynamics. Indometacin suppresses synthesis of Pg, reduces the level of the mediators causing inflammatory process. Troxevasinum reduces permeability of capillaries and improves microcirculation in the place of use.
Indications to use:
Bursitis, tendovaginitis, synovitis, varicosity, hemorrhoids, hematoma of traumatic genesis, state after a long immobilization.
Route of administration and doses:
Outwardly. To squeeze out 1-2 cm of gel of a tube and to apply with the easy rubbing movements on affected areas 2-3 times a day.
Side effects:
Allergic reactions (skin rash, dermahemia, small tortoiseshell, skin itch).
Contraindications:
Hypersensitivity, leukopenia, hemorrhagic diathesis.
Storage conditions:
Validity term: 2 years.
Issue conditions:
Without recipe
Packaging:
Gel for external use (a tuba aluminum) 45 g.